Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research ...
Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...
vegconomist12 小时
The Cultivated B Unveils Synthetic Growth Factor to Reduce Cultivated Meat Costs
Biomanufacturing company The Cultivated B has developed a synthetic molecule that could significantly reduce the cost of ...
Armed robbery in Revesby22 小时
FGF21 Triggers PPP6C for Liver Fibrosis Treatment
Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...
Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock ...
Fundamental Global Inc. (Nasdaq: FGF) (the “Company” or "Fundamental Global") today announced that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the ...
GEN5 天
Guanylhydrazone-Based Small Molecule Discovered That Mimics bFGF for Cell Culture Applications
The small-molecule discovery could help in overcoming cell culture bottlenecks such as rapid degradation and high production costs.
Anthraquinone compound Kanglexin investigated for treatment of atherosclerosis
Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...
BioWorld6 天
FGFR2/3 inhibitors reported in Genescience Pharmaceuticals patent
Genescience Pharmaceuticals Co. Ltd. has prepared and tested new fibroblast growth factor receptor 2 (FGFR2) and/or FGFR3 inhibitors reported to be useful for the treatment of cancer, ...
Medscape6 天
Bone-Derived Hormone Predicts Diabetic Kidney Disease Risk
Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, ...